Cardinal Health, Inc. (CAH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CAH Revenue Growth
Revenue Breakdown (FY 2025)
CAH's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CAH Revenue Analysis (2014–2025)
As of May 6, 2026, Cardinal Health, Inc. (CAH) generated trailing twelve-month (TTM) revenue of $250.55 billion, reflecting strong growth of +11.0% year-over-year. The most recent quarter (Q3 2026) recorded $60.94 billion in revenue, down 6.9% sequentially.
Looking at the longer-term picture, CAH's 5-year compound annual growth rate (CAGR) stands at +7.8%, indicating steady revenue expansion. The company achieved its highest annual revenue of $226.83 billion in 2024.
Revenue diversification analysis shows CAH's business is primarily driven by Pharmaceutical Member (92%), GMPD (6%), and Other Operating Segment (2%). With over half of revenue concentrated in Pharmaceutical Member, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MCK (+15.5% YoY), HSIC (+4.0% YoY), and OMI (-41.0% YoY), CAH has underperformed the peer group in terms of revenue growth. Compare CAH vs MCK →
CAH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CAHCurrent | $250.5B | +11.0% | +7.8% | 1.0% | |
 MCK | $359.1B | +15.5% | +9.2% | 1.2% | |
 HSIC | $13.2B | +4.0% | +5.4% | 5.7% | |
 OMI | $2.8B | -41.0% | -20.1% | 1.0% | |
 NXST | $4.9B | -8.4% | +1.9% | 17.2% | |
 JNJ | $88.8B | +3.7% | +1.6% | 24.9% |
CAH Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $222.58B | -1.9% | $8.17B | 3.7% | $2.27B | 1.0% |
| 2024 | $226.83B | +10.7% | $7.41B | 3.3% | $1.24B | 0.5% |
| 2023 | $204.98B | +13.0% | $6.89B | 3.4% | $752.0M | 0.4% |
| 2022 | $181.33B | +11.6% | $6.48B | 3.6% | $-607,000,000 | -0.3% |
| 2021 | $162.47B | +6.2% | $6.78B | 4.2% | $472.0M | 0.3% |
| 2020 | $152.92B | +5.1% | $6.87B | 4.5% | $-4,098,000,000 | -2.7% |
| 2019 | $145.53B | +6.4% | $6.83B | 4.7% | $2.06B | 1.4% |
| 2018 | $136.81B | +5.3% | $7.18B | 5.2% | $126.0M | 0.1% |
| 2017 | $129.98B | +6.9% | $6.54B | 5.0% | $2.12B | 1.6% |
| 2016 | $121.55B | +18.5% | $6.54B | 5.4% | $2.46B | 2.0% |
Full CAH Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CAH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CAH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CAH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCAH — Frequently Asked Questions
Quick answers to the most common questions about buying CAH stock.
Is CAH's revenue growth accelerating or slowing?
CAH maintains +11.0% revenue growth, in line with its 5-year CAGR of +7.8%. TTM revenue stands at $250.5B. Growth rate remains consistent with historical average.
What is CAH's long-term revenue growth rate?
Cardinal Health, Inc.'s 5-year revenue CAGR of +7.8% reflects the sustained expansion pattern. Current YoY growth of +11.0% is near this long-term average.
How is CAH's revenue distributed by segment?
CAH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.